Nano24

The new revolution in immunomodulators: Efficient & safer than steroids. Clinical stage company developing IP protected CD24 enriched exosome as a therapy for pulmonary & systemic diseases involving cytokine storm, the death junction for millions of lives per year. Our technology is based on decades of research into the biology of CD24 in the laboratory of Prof. Nadir Arber and Dr. Shiran Shapira at the Tel Aviv Sourasky Medical Centre. We imagined a world where every problem has a simple innovative solution. We now build that world.